INDICATED FOR USE AS A CONTRAST AGENT IN MAGNETIC RESONANCE ANGIOGRAPHY (MRA) TO EVALUATE AORTOILIAC OCCLUSIVE DISEASE (AIOD) IN ADULTS WITH KNOWN OR SUSPECTED PERIPHERAL VASCULAR DISEASE.
ADMINISTER GADOFOSVESET TRISODIUM INJECTION AS AN IV BOLUS INJECTION, MANUALLY OR BY POWER INJECTION, AT A DOSE OF 0.12 ML/KG BODY WEIGHT OVER A PERIOD OF TIME UP TO 30 SECONDS FOLLOWED BY A 25-30 ML NORMAL SALINE FLUSH.